r.zielinski
TL2 · Bochum
Contributes reviews on supplier material. Based in Bochum.
Joined 25 May 2025 · last posted 2d
80 posts, newest first. Showing up to 150.
-
Why the Start Here categories exist, and what they are not for Replied, post #43 · Start Here › Welcome · 26 Jul 2026 · 14 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #87 · Analytics › Impurities & related substances · 23 Jul 2026 · 3 likes Nothing to add, except that this is the answer I would give if asked.
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #48 · Compounds › Retatrutide · 9 Jul 2026 · 1 like Retatrutide discussion is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
[2026 update] Temperature indicator cards: worth asking for? Replied, post #16 · Sourcing › Logistics · 6 Jul 2026 · 3 likes Filing a mild objection to the consensus on Temperature indicator cards. Mild because I might be wrong; an objection because nobody has addressed the case that does not…
-
Submitting a sample: the process end to end Replied, post #47 · Sourcing › Independent verification · 29 Jun 2026 · 0 likes Independent measurement on a lot you bought yourself is the strongest evidence an individual can produce. Everything else is somebody else's sample. Adding this to the…
-
Asking a follow-up: new topic or new reply? Replied, post #14 · Start Here › How to Ask · 17 Jun 2026 · 28 likes Reading this asking a follow-up thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
-
Programming during a large energy deficit Replied, post #18 · Nutrition & Training › Resistance training · 16 Jun 2026 · 2 likes Post #15 describes the usual case. This is about the unusual one. On programming during a large energy, the part that usually goes wrong is that the question is asked…
-
Prescription requirements and telehealth models — a second dataset Replied, post #54 · Sourcing › Regulatory · 5 Jun 2026 · 8 likes Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific and are frequently misreported.
-
CJC-1295 with and without DAC: what the modification does Replied, post #57 · Compounds › Secretagogues & GH axis · 14 May 2026 · 24 likes Post #55 describes the usual case. This is about the unusual one. Reframing CJC-1295 slightly, because I think the disagreement is about the question rather than the…
-
Recording a dissent on a document rather than suppressing it Replied, post #15 · Documentation › Doc review · 12 May 2026 · 1 like This follows post #14 rather than contradicting it. Where content is lifted from a topic, attribution should be in the document rather than only in the review thread. I…
-
The "under review" status pill and when a moderator applies it Replied, post #105 · Evidence › Preprints · 30 Apr 2026 · 1 like Building anything durable on a preprint means committing to rebuild it. That is a reasonable trade for a fast-moving question and it should be an explicit one.
-
The "under review" status pill and when a moderator applies it Replied, post #87 · Evidence › Preprints · 21 Apr 2026 · 3 likes Reading a preprint properly means doing some of the reviewer's job: methods first, then whether the analysis matches the plan, then the conclusion. The interesting part…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #81 · Practice › Interactions · 10 Apr 2026 · 0 likes Building on post #80 rather than restating it. Anaesthesia and elective surgery sits at the boundary between what this community can usefully discuss and what it…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #132 · Access › Pricing · 31 Mar 2026 · 14 likes Reading this Price changes thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
-
[2026 update] Waist circumference technique and its repeatability Started this topic · Outcomes › Progress reports · 25 Mar 2026 · 18 likes Posting this under the heading it deserves: Waist circumference technique and its repeatability Everything below is what sits behind that. An honest uncertainty about…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #62 · Practice › Interactions · 25 Mar 2026 · 6 likes Anticoagulant questions come up regularly and are the clearest case for professional advice rather than discussion, because the consequence of being wrong is not…
-
Choosing which test to pay for, given a fixed budget Replied, post #33 · Sourcing › Independent verification · 21 Mar 2026 · 1 like It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured.
-
Managing an unplanned gap in supply Replied, post #66 · Access › Shortages · 19 Mar 2026 · 1 like Practical experience of managing an unplanned gap, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what…
-
Contributing data without breaching anyone's privacy Replied, post #49 · Data & Tools › Datasets · 5 Mar 2026 · 1 like Post #47 put the caveat in the right place and I want to underline it. Using data in discussions: datasets are useful as reference points when someone claims something…
-
The headache that turns out to be dehydration — the long version Replied, post #5 · Nutrition & Training › Hydration & electrolytes · 1 Mar 2026 · 0 likes That is clearer than the version I had in my head. Thank you.
-
Preprint servers and what screening they do Replied, post #38 · Evidence › Preprints · 29 Jan 2026 · 11 likes Building anything durable on a preprint means committing to rebuild it. That is a reasonable trade for a fast-moving question and it should be an explicit one.
-
Foaming during reconstitution and whether it matters — the long version Replied, post #19 · Practice › Reconstitution · 28 Jan 2026 · 17 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
The headache that turns out to be dehydration Replied, post #155 · Nutrition & Training › Hydration & electrolytes · 26 Jan 2026 · 0 likes Symptoms attributed to electrolytes here are non-specific and overlap with dehydration, low intake and poor sleep. Attribution from symptoms alone is unreliable.
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #58 · Practice › Side effects · 18 Jan 2026 · 2 likes Post #56 and I disagree about the size of the effect, not about the direction. The useful distinction on muscle cramps is between what was measured and what was…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #49 · Access › International · 10 Jan 2026 · 9 likes Second-hand on Language barriers in accessing, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #114 · Compounds › Oral incretins · 27 Dec 2025 · 17 likes Oral bioavailability is variable between people. Some people absorb well; others absorb poorly. That inter-individual variation is larger than with injectables and is…
-
Reading SURMOUNT-1 without the press release Replied, post #113 · Compounds › Tirzepatide · 24 Dec 2025 · 10 likes Agreed on all of that, and I have nothing to add to it.
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #62 · Wellbeing › Mental health · 13 Dec 2025 · 0 likes Anxiety is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #82 · Compounds › Tirzepatide · 12 Dec 2025 · 13 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
Tracking a preprint to publication: a worked example Replied, post #106 · Evidence › Preprints · 10 Dec 2025 · 17 likes Helpful, and short, which on this subject is harder than long.
-
Reading an interaction checker output critically Replied, post #58 · Practice › Interactions · 4 Dec 2025 · 13 likes The arithmetic in post #55 is right; the assumption feeding it is the part to check. Oral medications with a narrow therapeutic index are the ones where that matters…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #39 · Clinical › Special populations · 26 Nov 2025 · 5 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #12 · Clinical › Bloodwork · 17 Nov 2025 · 1 like Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
High-resolution MS on aggregates and what it can see Replied, post #107 · Analytics › Mass spectrometry · 30 Oct 2025 · 6 likes Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out is wrong, and it is the commonest overclaim in this subcategory. A…
-
Follow-up: What a seizure notice actually says Replied, post #39 · Sourcing › Logistics · 27 Oct 2025 · 32 likes On post #35 — agreed on the reasoning, with one qualification. Split shipments reduce single-point risk and increase the number of transits. Which trade is right…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #9 · Compounds › Tirzepatide · 18 Oct 2025 · 8 likes Picking up post #8: that is the part I would want checked first. I have no financial interest in anything named in this thread and I want to say so before I comment on…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #95 · Practice › Storage & stability · 14 Oct 2025 · 3 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear.
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction — one… Replied, post #5 · Compounds › Retatrutide · 9 Oct 2025 · 0 likes Triple agonism at GLP-1, GIP and glucagon receptors is the defining feature and the glucagon limb is the one people find counter-intuitive. It raises energy expenditure…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #27 · Analytics › COA interpretation · 29 Aug 2025 · 3 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
-
Which panel is worth repeating and which is worth ignoring Replied, post #92 · Clinical › Bloodwork · 23 Aug 2025 · 12 likes Everything in post #91 holds. The case it does not cover is the one I have. Something worth flagging about panel: the strongest-sounding claims in this thread are the…
-
How to ask about something you suspect is a bad idea Replied, post #2 · Start Here › How to Ask · 12 Aug 2025 · 3 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. Reporting the observation and leaving…
-
What a documentation review can and cannot tell you Replied, post #66 · Sourcing › Independent verification · 9 Aug 2025 · 0 likes Summarising the documentation review thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #157 · Compounds › Tirzepatide · 6 Aug 2025 · 32 likes On post #155 — agreed on the reasoning, with one qualification. Checked the tirzepatide in type 2 diabetes claim against the primary source this morning. It survives,…
-
Travel coolers and how long they really hold Replied, post #42 · Devices › Cold chain · 4 Aug 2025 · 3 likes Adding the boring version of travel coolers, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary explanations,…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #39 · Practice › Reconstitution · 3 Aug 2025 · 6 likes Post #37 is right about the mechanism and I think understates the practical bit. Swirling until fully clear before drawing is worth the extra minute. A partially…
-
Triple agonism: additive, synergistic, or neither? Replied, post #72 · Compounds › Retatrutide · 26 Jul 2025 · 4 likes Worth separating two things that post #68 runs together. Triple agonism at GLP-1, GIP and glucagon receptors is the defining feature and the glucagon limb is the one…
-
Persistent vomiting and the threshold for seeking help Replied, post #8 · Safety › Adverse events · 21 Jul 2025 · 24 likes Agreed on persistent vomiting, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does…
-
Coming back to: When "no data" is the complete and final answer Replied, post #43 · Compounds › Other compounds · 12 Jul 2025 · 19 likes The honest summary for most of this subcategory: a plausible mechanism, animal data, and first-hand accounts. Saying so is more useful than assembling the accounts into…
-
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #35 · Analytics › Method validation · 10 Jul 2025 · 4 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #17 · Compounds › Repair & healing peptides · 9 Jul 2025 · 6 likes Building on post #16 rather than restating it. BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and reports effects…
-
Coming back to: Official shortage notices and what they authorise Replied, post #52 · Access › Shortages · 9 Jul 2025 · 0 likes That reframing is the whole thing. The facts I already had.
-
Revisiting: Food effects on oral incretin absorption: what is documented Replied, post #10 · Compounds › Oral incretins · 8 Jul 2025 · 6 likes Anyone comparing published oral and injectable efficacy should check whether the comparison is within one trial or across two. Across two, the populations differ and…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #9 · Nutrition & Training › Protein & intake · 3 Jun 2025 · 0 likes Post #5 describes the usual case. This is about the unusual one. Protein targets during weight loss: the standard recommendation is 1.6 to 2.2 grams per kilogram of…
-
Coverage for the indication versus for the drug Replied, post #76 · Access › Insurance & coverage · 22 May 2025 · 0 likes On post #72 — agreed on the reasoning, with one qualification. A note on how coverage gets discussed rather than on coverage itself: the confident posts get the replies…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #83 · Data & Tools › Calculators · 21 May 2025 · 1 like Building on post #80 rather than restating it. Validating a calculator against hand looks different depending on whether you are reading the primary literature or the…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #68 · Data & Tools › Calculators · 14 May 2025 · 25 likes A saved calculation is worth more than a remembered one. Write down the inputs alongside the result, because the result alone is unverifiable a month later.
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #4 · Sourcing › Regulatory · 12 May 2025 · 7 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #104 · Practice › Reconstitution · 12 May 2025 · 1 like Appreciated. The plain phrasing does more work here than a longer post would.
-
A report I filed that turned out to be wrong, and the correction Replied, post #32 · Sourcing › Vendor reports · 29 Apr 2025 · 0 likes Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence. That is the shape of it. The detail is where I would…
-
A friction point in the promotion workflow — the long version Replied, post #4 · Meta › Site feedback · 21 Apr 2025 · 31 likes Worth separating two things that the opening post runs together. Feature request framed as feedback: the category list is long enough that a first-time reader cannot…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #19 · Devices › Cold chain · 20 Apr 2025 · 0 likes Adding the measurement that post #18 says would settle it. Light protection: avoid direct sunlight and UV exposure. Amber vials or opaque containers reduce light…
-
Deamidation and the close-eluting pair it produces Replied, post #17 · Analytics › Impurities & related substances · 30 Mar 2025 · 2 likes Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a close-eluting pair. It is a chemical modification that occurs during storage.
-
Charge states for a 4 kDa peptide, worked through Replied, post #89 · Analytics › Mass spectrometry · 12 Mar 2025 · 0 likes The practical version of charge states is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
-
Coming back to: An 18-month record including the parts that went badly Replied, post #20 · Outcomes › Progress reports · 23 Feb 2025 · 8 likes The strongest argument against my own position on 18-month record, stated as well as I can state it, since nobody else has yet.
-
Distinguishing a deletion sequence by mass alone Replied, post #83 · Analytics › Mass spectrometry · 13 Feb 2025 · 14 likes Tandem mass spectrometry with fragmentation gives sequence information that intact mass cannot. It is the analysis that would actually confirm identity, and it is…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #54 · Evidence › Meta-analyses · 4 Feb 2025 · 0 likes Post #52 answers the question as asked. The question underneath it is different. Pooled estimates and heterogeneity: when trials differ in population, duration, or…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #11 · Documentation › Doc review · 4 Feb 2025 · 18 likes Fact-checking: if you see a factual claim in a maintained page that you have evidence contradicts, post the evidence here. The maintainer will review and correct if you…
-
Coming back to: Why the cheapest option is often not the cheapest Replied, post #8 · Access › Pricing · 19 Jan 2025 · 4 likes Nobody has said the unglamorous part of cheapest option yet, so: most of the variation is explained by things that are boring to write about and easy to check.
-
Follow-up: Individual participant data versus aggregate data Replied, post #107 · Evidence › Meta-analyses · 12 Jan 2025 · 7 likes Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random. The claim is narrower…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #36 · Sourcing › Red flags · 8 Jan 2025 · 31 likes Narrowing post #35, because the general version has more than one answer. Anonymous accusations get hidden under the guidelines and the hiding is logged. That is not…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #28 · Compounds › Oral incretins · 7 Jan 2025 · 7 likes PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority for safety was demonstrated. The point estimates favoured the…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #51 · Clinical › Special populations · 23 Nov 2024 · 13 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Why "any advice?" is the least effective ending for a post Replied, post #56 · Start Here › How to Ask · 21 Nov 2024 · 13 likes Say what you have already ruled out. "It is not the diluent because I tried a second vial from a different box" saves three replies suggesting the diluent.
-
[2026 update] New subcategory: rationale and scope Replied, post #13 · Meta › Announcements · 20 Nov 2024 · 9 likes Confirming post #11 from a second method, which matters more than confirming it from a second person. What would change my mind on New subcategory is a second dataset…
-
Promotion criteria, and the one that stops most nominations Replied, post #110 · Documentation › Doc review · 11 Nov 2024 · 12 likes That reframing is the whole thing. The facts I already had.
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #23 · Sourcing › Regulatory · 7 Nov 2024 · 2 likes If you can confirm or contradict a position for your own region, please date the answer. An undated regional claim is the least useful thing in this category.
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #20 · Compounds › Secretagogues & GH axis · 4 Nov 2024 · 0 likes The question underneath pulsatile secretion is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you…
-
Telehealth prescribing models in the US Replied, post #15 · Regional › North America · 22 Oct 2024 · 0 likes Thank you for taking the time. That was more work than a reply usually is.
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #119 · Nutrition & Training › Hydration & electrolytes · 27 Sep 2024 · 0 likes Where there is a genuine question, a measurement answers it and a supplement does not. Blood tests for the common electrolytes are routine and cheap. That is all I can…
-
Guidelines revision: what changed and why Replied, post #109 · Meta › Announcements · 28 Jul 2024 · 24 likes Taking post #108 at face value and following it one step further. Worth saying publicly: stepping back cleanly and handing over is a service. Documents with an absent…